Published in Prog Neuropsychopharmacol Biol Psychiatry on December 10, 2010
Randomized controlled trial comparing changes in serum prolactin and weight among female patients with first-episode schizophrenia over 12 months of treatment with risperidone or quetiapine. Shanghai Arch Psychiatry (2014) 0.80
Low striatal dopamine receptor availability linked to caloric intake during abstinence from chronic methamphetamine abuse. Mol Psychiatry (2011) 0.78
Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study. Clin Psychopharmacol Neurosci (2016) 0.77
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine? Neuropsychiatr Dis Treat (2014) 0.76
The genetic determinants of smoking. Chest (2003) 2.88
Non-prescribed use of pain relievers among adolescents in the United States. Drug Alcohol Depend (2007) 2.11
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. J Clin Psychopharmacol (2006) 1.57
Buprenorphine treatment: factors and first-hand experiences for providers to consider. J Addict Dis (2007) 1.46
A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J Clin Psychiatry (2011) 1.45
Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study. Compr Psychiatry (2007) 1.41
Prescription pain reliever abuse and dependence among adolescents: a nationally representative study. J Am Acad Child Adolesc Psychiatry (2008) 1.40
Decreased plasma antioxidants in patients with Alzheimer's disease. Int J Geriatr Psychiatry (2006) 1.37
Telephone enhancement of long-term engagement (TELE) in continuing care for substance abuse treatment: a NIDA clinical trials network (CTN) study. Am J Addict (2007) 1.37
An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study. J Stud Alcohol Drugs (2009) 1.27
A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet (2003) 1.25
Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. J Clin Psychiatry (2002) 1.14
The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. Contemp Clin Trials (2008) 1.14
The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Drug Alcohol Depend (2009) 1.13
Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients. Psychosomatics (2009) 1.10
Comment and reply on: antidepressant for depressed patients with pain. Expert Opin Investig Drugs (2012) 1.08
Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population. Psychiatr Genet (2003) 1.07
Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. Psychopharmacology (Berl) (2009) 1.05
Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data. CNS Drugs (2011) 1.05
Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study. Am J Addict (2009) 1.03
Paroxetine mesylate: comparable to paroxetine hydrochloride? Expert Opin Pharmacother (2010) 1.02
Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.02
Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise. Curr Neuropharmacol (2009) 0.98
Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures. J Clin Psychiatry (2012) 0.98
Does minocycline have antidepressant effect? Biomed Pharmacother (2008) 0.97
Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications. Clin Neuropharmacol (2011) 0.97
Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial. Addict Biol (2008) 0.96
HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study. J Acquir Immune Defic Syndr (2010) 0.95
Aripiprazole augmentation for treatment of patients with inadequate antidepressants response. Depress Anxiety (2007) 0.95
Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study. Int Clin Psychopharmacol (2005) 0.95
Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.94
Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Neuropsychobiology (2011) 0.93
Tardive dystonic symptoms associated with aripiprazole treatment. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.93
A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome. Psychosomatics (2009) 0.93
Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping. Neurosci Res (2005) 0.92
Hallucinogen use disorders among adult users of MDMA and other hallucinogens. Am J Addict (2008) 0.91
Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder. Eur Arch Psychiatry Clin Neurosci (2011) 0.91
Experiences and barriers to implementation of clinical practice guideline for depression in Korea. BMC Psychiatry (2013) 0.90
The relationship between fibromyalgia and major depressive disorder: a comprehensive review. Curr Med Res Opin (2008) 0.90
Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion. Expert Rev Neurother (2007) 0.90
Triple reuptake inhibitors: the next generation of antidepressants. Curr Neuropharmacol (2008) 0.90
Paroxetine: current status in psychiatry. Expert Rev Neurother (2007) 0.90
A functional prodynorphin promoter polymorphism and opioid dependence. Psychiatr Genet (2005) 0.90
Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: increased evidence for linkage and reduced linkage interval. Eur J Hum Genet (2005) 0.89
Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study. Am J Addict (2008) 0.89
Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence. CNS Drugs (2008) 0.89
Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder. CNS Drugs (2013) 0.89
Short-, intermediate-, and long-term outcomes of Pennsylvania's continuum of tobacco education pilot project. Nicotine Tob Res (2009) 0.89
fMRI investigation on cue-induced smoking craving. J Psychiatr Res (2005) 0.89
Working memory processing of facial images in schizophrenia: fMRI investigation. Int J Neurosci (2005) 0.88
An integrated alcohol abuse and medical treatment model for patients with hepatitis C. Dig Dis Sci (2011) 0.88
A case of brief psychosis associated with an arachnoid cyst. Psychiatry Clin Neurosci (2002) 0.87
Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. J Psychiatr Res (2006) 0.87
Quetiapine XR: current status for the treatment of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.87
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study. J Clin Psychiatry (2010) 0.87
Case-control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics. Eur Arch Psychiatry Clin Neurosci (2011) 0.87
Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects. Biomed Pharmacother (2008) 0.86
Second-generation antipsychotics in the treatment of major depressive disorder: current evidence. Expert Rev Neurother (2013) 0.85
Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence. Am J Med Genet B Neuropsychiatr Genet (2005) 0.85
Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet (2007) 0.85
Polymorphism in the serotonin transporter gene and response to treatment in African American cocaine and alcohol-abusing individuals. Addict Biol (2005) 0.85
A review of current evidence for vilazodone in major depressive disorder. Int J Psychiatry Clin Pract (2013) 0.85
Altered verbal working memory process in patients with Alzheimer's disease: an fMRI investigation. Neuropsychobiology (2008) 0.84
Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal. Eur J Pharmacol (2007) 0.84
Mirtazapine may have the propensity for developing a restless legs syndrome? A case report. Psychiatry Clin Neurosci (2002) 0.84
Interleukin-10 gene promoter polymorphism is not associated with schizophrenia in the Korean population. Psychiatry Clin Neurosci (2003) 0.83
A randomized controlled trial of the efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with residual symptoms of major depressive disorder after treatment with escitalopram. J Clin Psychiatry (2013) 0.83
Paliperidone-associated atypical neuroleptic malignant syndrome: a case report. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.83
Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.83
Interrelationships among pain, disability, and psychological factors in young Korean conscripts with lumbar disc herniation. Mil Med (2006) 0.83
Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. Neurosci Lett (2005) 0.83
Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls. Psychiatry Res (2006) 0.83
Atypical depression: a comprehensive review. CNS Drugs (2009) 0.83
Long-acting injectable naltrexone for the treatment of alcohol dependence. Expert Rev Neurother (2007) 0.83
Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants. Expert Opin Pharmacother (2009) 0.83
Dysbindin gene (DTNBP1) and schizophrenia in Korean population. Eur Arch Psychiatry Clin Neurosci (2009) 0.82
Case-control association study of 36 single-nucleotide polymorphisms within 10 candidate genes for major depression and bipolar disorder. Psychiatry Res (2012) 0.82
Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.82
Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder. Behav Brain Funct (2012) 0.82
Clinical issues in use of atypical antipsychotics for depressed patients. CNS Drugs (2013) 0.81
Paroxetine: safety and tolerability issues. Expert Opin Drug Saf (2008) 0.81
The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Clin Psychopharmacol (2008) 0.81
Very low dose quetiapine-induced galactorrhea in combination with venlafaxine. Hum Psychopharmacol (2004) 0.81
Birth order and sibling sex ratio in homosexual transsexual South Korean men: Effects of the male-preference stopping rule. Psychiatry Clin Neurosci (2007) 0.81
Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder. Psychiatry Res (2012) 0.81
History of depressive and/or anxiety disorders as a predictor of treatment response: a post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.81